Prevalence of Hepatitis E Virus Antibodies, Israel, 2009–2010

@inproceedings{Mor2015PrevalenceOH,
  title={Prevalence of Hepatitis E Virus Antibodies, Israel,
2009–2010},
  author={Orna Mor and Ravit Bassal and Michal Michaeli and Marina Wax and Daniela Ram and Oranit Cohen-Ezra and Dani Cohen and Ella Mendelson and Ziv Ben-Ari and Tamy Shohat},
  booktitle={Emerging infectious diseases},
  year={2015}
}
We investigated prevalence of hepatitis E virus in a sample of the population of Israel. The overall seroprevalence of antibodies to the virus was 10.6% (95% CI 8.4%-13.0%); age-adjusted prevalence was 7.6%. Seropositivity was associated with age, Arab ethnicity, low socioeconomic status, and birth in Africa, Asia, or the former Soviet Union. 

Tables and Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 12 REFERENCES

Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients.

  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
  • 2013
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Socio-economic, industrial and cultural parameters of pig-borne infections.

  • Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2013
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Hepatitis E.

  • Current opinion in infectious diseases
  • 2013

Viral Hepatitis A to E in South Mediterranean Countries

  • Mediterranean journal of hematology and infectious diseases
  • 2010
VIEW 1 EXCERPT

Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2008
VIEW 2 EXCERPTS